PH sensitive prodrugs of 2,6-Diisopropylphenol
    1.
    发明授权
    PH sensitive prodrugs of 2,6-Diisopropylphenol 有权
    2,6-二异丙基苯酚的PH敏感前药

    公开(公告)号:US07250412B2

    公开(公告)日:2007-07-31

    申请号:US10514303

    申请日:2004-03-15

    CPC分类号: C07D295/18

    摘要: The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.

    摘要翻译: 本发明涉及2,6-二异丙基苯酚(Propofol)的水溶性衍生物。 该化合物作为2,6-二异丙基苯酚的前体药物,并快速代谢到丙泊酚,从而提供了不溶于水的2,6-二异丙基苯酚的替代物。 还公开了包含这些化合物的药物组合物,诱导和维持麻醉或镇静的方法以及利用包含这些化合物的药物组合物治疗神经变性疾病的方法及其制备方法。

    pH sensitive prodrugs of 2,6-diisopropylphenol
    2.
    发明授权
    pH sensitive prodrugs of 2,6-diisopropylphenol 失效
    2,6-二异丙基苯酚的pH敏感前药

    公开(公告)号:US07691904B2

    公开(公告)日:2010-04-06

    申请号:US11881143

    申请日:2007-07-24

    CPC分类号: C07D295/18

    摘要: The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.

    摘要翻译: 本发明涉及2,6-二异丙基苯酚(Propofol)的水溶性衍生物。 该化合物作为2,6-二异丙基苯酚的前体药物,并快速代谢到丙泊酚,从而提供了不溶于水的2,6-二异丙基苯酚的替代物。 还公开了包含这些化合物的药物组合物,诱导和维持麻醉或镇静的方法以及利用包含这些化合物的药物组合物治疗神经变性疾病的方法及其制备方法。

    pH sensitive prodrugs of 2,6-diisopropylphenol
    3.
    发明申请
    pH sensitive prodrugs of 2,6-diisopropylphenol 失效
    2,6-二异丙基苯酚的pH敏感前药

    公开(公告)号:US20080248093A1

    公开(公告)日:2008-10-09

    申请号:US11881143

    申请日:2007-07-24

    CPC分类号: C07D295/18

    摘要: The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.

    摘要翻译: 本发明涉及2,6-二异丙基苯酚(Propofol)的水溶性衍生物。 该化合物作为2,6-二异丙基苯酚的前体药物,并快速代谢到丙泊酚,从而提供了不溶于水的2,6-二异丙基苯酚的替代物。 还公开了包含这些化合物的药物组合物,诱导和维持麻醉或镇静的方法以及利用包含这些化合物的药物组合物治疗神经变性疾病的方法及其制备方法。

    Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
    7.
    发明授权
    Preparation and utility of substituted imidazopyridine compounds with hypnotic effects 有权
    具有催眠作用的取代咪唑并吡啶化合物的制备和应用

    公开(公告)号:US07772248B2

    公开(公告)日:2010-08-10

    申请号:US11755634

    申请日:2007-05-30

    CPC分类号: C07D471/04

    摘要: The present disclosure is directed to modulators of GABAA receptors and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment and/or management of sleep disorders and/or for providing a patient in need with a hypnotic, anxiolytic or anti-convulsive effect are described.

    摘要翻译: 本公开涉及GABA A受体及其药学上可接受的盐和前药的调节剂,其化学合成以及这些化合物用于治疗和/或治疗睡眠障碍和/或提供需要的患者的医学用途 描述了催眠,抗焦虑或抗惊厥作用。

    Substituted amino alcohols
    8.
    发明授权
    Substituted amino alcohols 有权
    取代的氨基醇

    公开(公告)号:US07767860B2

    公开(公告)日:2010-08-03

    申请号:US12203581

    申请日:2008-09-03

    IPC分类号: C07C215/18 A61K31/131

    摘要: Disclosed herein are substituted amino alcohol anti-mycobacterial agents and/or chelation therapy agents of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

    摘要翻译: 本文公开了式I的取代的氨基醇抗分枝杆菌和/或螯合治疗剂,其制备方法,其药物组合物及其使用方法。